Use of electronic medical records to describe the prevalence of allergic diseases in Canada

Simple item page
dc.contributor.authorSinger, Alexander G.
dc.contributor.authorKosowan, Leanne
dc.contributor.authorNankissoor, Nerissa
dc.contributor.authorPhung, Ryan
dc.contributor.authorProtudjer, Jennifer L. P.
dc.contributor.authorAbrams, Elissa M.
dc.date.accessioned2021-09-01T03:26:13Z
dc.date.issued2021-08-18
dc.date.updated2021-09-01T03:26:13Z
dc.description.abstractAbstract Background Leveraging the data management resources of the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) is a viable approach for describing the prevalence of allergic disease documented in primary care settings. Methods The dataset used for this study was inclusive of data from EMR initiation up to Dec 31st 2018. The sample included 1235 primary care providers representing 1,556,472 patients across Canada. Results In total, there were 536,005 patients with a documented allergy that fit into one of the 10 suggested categories. The allergy table includes 718,032 distinct entries representing 564,242 unique patients, which is 36.3% of the patients within the CPCSSN repository. The most common allergies recorded were drug allergy (39.0%), beta-lactam allergy (14.4%), environmental allergy (11.0%), and food allergy (8.0%). Anticipated upcoming studies include physician-documented drug allergy with a focus on beta-lactam allergy, as well as stinging insect allergy, among others. To our knowledge, these will also be the first such prevalence studies of primary care physician-documented allergic disease done in Canada. Interpretation The CPCSSN dataset represents electronic medical records from 1.5 million patients across Canada including documentation of allergic diseases. This dataset provides a national representative population to describe and characterize Canadian patients with common allergic conditions. This robust dataset provides the opportunity for health surveillance, and in particular data to explore the impact of allergic disease on primary care practice. Trial registration Not applicable.
dc.identifier.citationAllergy, Asthma & Clinical Immunology. 2021 Aug 18;17(1):85
dc.identifier.urihttps://doi.org/10.1186/s13223-021-00580-z
dc.identifier.urihttp://hdl.handle.net/1993/35887
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderThe Author(s)
dc.titleUse of electronic medical records to describe the prevalence of allergic diseases in Canada
dc.typeJournal Article
local.author.affiliationRady Faculty of Health Sciencesen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13223_2021_Article_580.pdf
Size:
1.42 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works